Bioadaptives (BDPT) Equity Ratio (2016 - 2025)
Bioadaptives' Equity Ratio history spans 8 years, with the latest figure at 9.43 for Q4 2025.
- On a quarterly basis, Equity Ratio fell 68.68% to 9.43 in Q4 2025 year-over-year; TTM through Dec 2025 was 9.43, a 68.68% decrease, with the full-year FY2025 number at 9.43, down 68.68% from a year prior.
- Equity Ratio hit 9.43 in Q4 2025 for Bioadaptives, up from 11.78 in the prior quarter.
- Over the last five years, Equity Ratio for BDPT hit a ceiling of 3.48 in Q3 2023 and a floor of 213.82 in Q2 2024.
- Historically, Equity Ratio has averaged 33.55 across 5 years, with a median of 15.03 in 2023.
- Biggest five-year swings in Equity Ratio: crashed 1018.35% in 2024 and later surged 97.89% in 2025.
- Tracing BDPT's Equity Ratio over 5 years: stood at 7.36 in 2021, then plummeted by 428.79% to 38.9 in 2022, then surged by 59.3% to 15.83 in 2023, then surged by 64.7% to 5.59 in 2024, then crashed by 68.68% to 9.43 in 2025.
- Business Quant data shows Equity Ratio for BDPT at 9.43 in Q4 2025, 11.78 in Q3 2025, and 4.52 in Q2 2025.